191 related articles for article (PubMed ID: 35881484)
1. Dichloroacetate improves mitochondrial function, physiology, and morphology in FBXL4 disease models.
Lavorato M; Nakamaru-Ogiso E; Mathew ND; Herman E; Shah N; Haroon S; Xiao R; Seiler C; Falk MJ
JCI Insight; 2022 Aug; 7(16):. PubMed ID: 35881484
[TBL] [Abstract][Full Text] [Related]
2. Characterization of the C584R variant in the mtDNA depletion syndrome gene FBXL4, reveals a novel role for FBXL4 as a regulator of mitochondrial fusion.
Sabouny R; Wong R; Lee-Glover L; Greenway SC; Sinasac DS; ; Khan A; Shutt TE
Biochim Biophys Acta Mol Basis Dis; 2019 Nov; 1865(11):165536. PubMed ID: 31442532
[TBL] [Abstract][Full Text] [Related]
3. Pre-clinical evaluation of cysteamine bitartrate as a therapeutic agent for mitochondrial respiratory chain disease.
Guha S; Konkwo C; Lavorato M; Mathew ND; Peng M; Ostrovsky J; Kwon YJ; Polyak E; Lightfoot R; Seiler C; Xiao R; Bennett M; Zhang Z; Nakamaru-Ogiso E; Falk MJ
Hum Mol Genet; 2019 Jun; 28(11):1837-1852. PubMed ID: 30668749
[TBL] [Abstract][Full Text] [Related]
4. Molecular and clinical spectra of FBXL4 deficiency.
El-Hattab AW; Dai H; Almannai M; Wang J; Faqeih EA; Al Asmari A; Saleh MAM; Elamin MAO; Alfadhel M; Alkuraya FS; Hashem M; Aldosary MS; Almass R; Almutairi FB; Alsagob M; Al-Owain M; Al-Sharfa S; Al-Hassnan ZN; Rahbeeni Z; Al-Muhaizea MA; Makhseed N; Foskett GK; Stevenson DA; Gomez-Ospina N; Lee C; Boles RG; Schrier Vergano SA; Wortmann SB; Sperl W; Opladen T; Hoffmann GF; Hempel M; Prokisch H; Alhaddad B; Mayr JA; Chan W; Kaya N; Wong LC
Hum Mutat; 2017 Dec; 38(12):1649-1659. PubMed ID: 28940506
[TBL] [Abstract][Full Text] [Related]
5. FBXL4 defects are common in patients with congenital lactic acidemia and encephalomyopathic mitochondrial DNA depletion syndrome.
Dai H; Zhang VW; El-Hattab AW; Ficicioglu C; Shinawi M; Lines M; Schulze A; McNutt M; Gotway G; Tian X; Chen S; Wang J; Craigen WJ; Wong LJ
Clin Genet; 2017 Apr; 91(4):634-639. PubMed ID: 27743463
[TBL] [Abstract][Full Text] [Related]
6. The pursuit of precision mitochondrial medicine: Harnessing preclinical cellular and animal models to optimize mitochondrial disease therapeutic discovery.
Falk MJ
J Inherit Metab Dis; 2021 Mar; 44(2):312-324. PubMed ID: 33006762
[TBL] [Abstract][Full Text] [Related]
7. FBXL4 deficiency increases mitochondrial removal by autophagy.
Alsina D; Lytovchenko O; Schab A; Atanassov I; Schober FA; Jiang M; Koolmeister C; Wedell A; Taylor RW; Wredenberg A; Larsson NG
EMBO Mol Med; 2020 Jul; 12(7):e11659. PubMed ID: 32525278
[TBL] [Abstract][Full Text] [Related]
8. Mutations in FBXL4, encoding a mitochondrial protein, cause early-onset mitochondrial encephalomyopathy.
Gai X; Ghezzi D; Johnson MA; Biagosch CA; Shamseldin HE; Haack TB; Reyes A; Tsukikawa M; Sheldon CA; Srinivasan S; Gorza M; Kremer LS; Wieland T; Strom TM; Polyak E; Place E; Consugar M; Ostrovsky J; Vidoni S; Robinson AJ; Wong LJ; Sondheimer N; Salih MA; Al-Jishi E; Raab CP; Bean C; Furlan F; Parini R; Lamperti C; Mayr JA; Konstantopoulou V; Huemer M; Pierce EA; Meitinger T; Freisinger P; Sperl W; Prokisch H; Alkuraya FS; Falk MJ; Zeviani M
Am J Hum Genet; 2013 Sep; 93(3):482-95. PubMed ID: 23993194
[TBL] [Abstract][Full Text] [Related]
9. A novel mutation in FBXL4 in a Norwegian child with encephalomyopathic mitochondrial DNA depletion syndrome 13.
Barøy T; Pedurupillay CR; Bliksrud YT; Rasmussen M; Holmgren A; Vigeland MD; Hughes T; Brink M; Rodenburg R; Nedregaard B; Strømme P; Frengen E; Misceo D
Eur J Med Genet; 2016 Jun; 59(6-7):342-6. PubMed ID: 27182039
[TBL] [Abstract][Full Text] [Related]
10. Combinatorial glucose, nicotinic acid and N-acetylcysteine therapy has synergistic effect in preclinical C. elegans and zebrafish models of mitochondrial complex I disease.
Guha S; Mathew ND; Konkwo C; Ostrovsky J; Kwon YJ; Polyak E; Seiler C; Bennett M; Xiao R; Zhang Z; Nakamaru-Ogiso E; Falk MJ
Hum Mol Genet; 2021 May; 30(7):536-551. PubMed ID: 33640978
[TBL] [Abstract][Full Text] [Related]
11. Clinical, morphological, biochemical, imaging and outcome parameters in 21 individuals with mitochondrial maintenance defect related to FBXL4 mutations.
Huemer M; Karall D; Schossig A; Abdenur JE; Al Jasmi F; Biagosch C; Distelmaier F; Freisinger P; Graham BH; Haack TB; Hauser N; Hertecant J; Ebrahimi-Fakhari D; Konstantopoulou V; Leydiker K; Lourenco CM; Scholl-Bürgi S; Wilichowski E; Wolf NI; Wortmann SB; Taylor RW; Mayr JA; Bonnen PE; Sperl W; Prokisch H; McFarland R
J Inherit Metab Dis; 2015 Sep; 38(5):905-14. PubMed ID: 25868664
[TBL] [Abstract][Full Text] [Related]
12. N-acetylcysteine and vitamin E rescue animal longevity and cellular oxidative stress in pre-clinical models of mitochondrial complex I disease.
Polyak E; Ostrovsky J; Peng M; Dingley SD; Tsukikawa M; Kwon YJ; McCormack SE; Bennett M; Xiao R; Seiler C; Zhang Z; Falk MJ
Mol Genet Metab; 2018 Apr; 123(4):449-462. PubMed ID: 29526616
[TBL] [Abstract][Full Text] [Related]
13. FBXL4: safeguarding against mitochondrial depletion through suppression of mitophagy.
Kulkarni P; Nguyen-Dien GT; Kozul KL; Pagan JK
Autophagy; 2024 Jun; 20(6):1459-1461. PubMed ID: 38423516
[TBL] [Abstract][Full Text] [Related]
14. Mutations in FBXL4 cause mitochondrial encephalopathy and a disorder of mitochondrial DNA maintenance.
Bonnen PE; Yarham JW; Besse A; Wu P; Faqeih EA; Al-Asmari AM; Saleh MA; Eyaid W; Hadeel A; He L; Smith F; Yau S; Simcox EM; Miwa S; Donti T; Abu-Amero KK; Wong LJ; Craigen WJ; Graham BH; Scott KL; McFarland R; Taylor RW
Am J Hum Genet; 2013 Sep; 93(3):471-81. PubMed ID: 23993193
[TBL] [Abstract][Full Text] [Related]
15. Pharmacologic modeling of primary mitochondrial respiratory chain dysfunction in zebrafish.
Byrnes J; Ganetzky R; Lightfoot R; Tzeng M; Nakamaru-Ogiso E; Seiler C; Falk MJ
Neurochem Int; 2018 Jul; 117():23-34. PubMed ID: 28732770
[TBL] [Abstract][Full Text] [Related]
16. Novel homozygous mutation in the FBXL4 gene is associated with mitochondria DNA depletion syndrome-13.
Wang S; Lin L; Wang Y; Wang A; Liu Z; Wu S; Lan X; Jia J; Zhang Y; Yuan F; Wang C; Luo X; Sun X; Avula SK; Tolaymat A; Liu C; Ren Y; Chen Y
J Neurol Sci; 2020 Sep; 416():116948. PubMed ID: 32559514
[TBL] [Abstract][Full Text] [Related]
17. Different clinical presentation in a patient with two novel pathogenic variants of the FBXL4 gene.
Köse E; Köse M; Edizer S; Akışın Z; Yılmaz ZB; Şahin A; Genel F
Turk J Pediatr; 2020; 62(4):652-656. PubMed ID: 32779419
[TBL] [Abstract][Full Text] [Related]
18. Dichloroacetate and thiamine improve survival and mitochondrial stress in a C. elegans model of dihydrolipoamide dehydrogenase deficiency.
Broxton CN; Kaur P; Lavorato M; Ganesh S; Xiao R; Mathew ND; Nakamaru-Ogiso E; Anderson VE; Falk MJ
JCI Insight; 2022 Oct; 7(20):. PubMed ID: 36278487
[TBL] [Abstract][Full Text] [Related]
19. The first case with FBXL4 mutation successfully treated with a parenteral ketogenic diet for lactic acidosis.
İnci A; Aktaş E; Cengiz Ergin FB; Okur İ; Biberoğlu G; Ezgü FS; Tümer L
JPEN J Parenter Enteral Nutr; 2021 Nov; 45(8):1788-1792. PubMed ID: 33882172
[TBL] [Abstract][Full Text] [Related]
20. Propionyl-CoA carboxylase pcca-1 and pccb-1 gene deletions in Caenorhabditis elegans globally impair mitochondrial energy metabolism.
Chapman KA; Ostrovsky J; Rao M; Dingley SD; Polyak E; Yudkoff M; Xiao R; Bennett MJ; Falk MJ
J Inherit Metab Dis; 2018 Mar; 41(2):157-168. PubMed ID: 29159707
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
